PE/VC investors
Private Equity (PE) and Venture Capital (VC) investors are the catalysts of innovation and growth in the business world. PE firms primarily target established companies, seeking to optimize operations and unlock value through strategic investments and management expertise. They focus on long-term growth and profitability, often preparing businesses for a future sale or IPO. VC investors, by contrast, are the adventurers of finance, injecting capital into high-potential startups and early-stage companies. They embrace risk for the possibility of outsized returns, often becoming invaluable advisors. Both investor types not only bring capital but also strategic guidance, industry connections, and market insights, propelling their portfolio companies towards success.
Investors (6,251)
Investor
Description
More information
Medical Technology Venture Partners
At MedTech Venture Partners, we fund and support medical technology entrepreneurs. Combined, our team has overseen the conception, development, and launch of over 30 medical devices and diagnostics products. We scaled early stage device businesses, operated large ones, we have extensive clinical and regulatory experience globally, and participated in buying and selling technologies, products, and companies. We believe our experience allows us to better understand device entrepreneurs and help them succeed. Together with our partners at UCSF we are building an exciting ecosystem around early stage medical devices.
Mediterra
Team of 15 investment professionals who have led US$2 billion of equity investments in 31 companies, 11 sectors and 11 different countries. Consumer driven, Export driven, B2B driven<br />
INDEPENDENT FIRM<br />
With international and local investors<br />
LOCAL INVESTOR BASE<br />
Top industrial families with leading positions in 10 sectors in Turkey<br />
ENVIRONMENTAL, SOCIAL AND CORPORATE GOVERNANCE (ESG)<br />
ESG best practices are part of our investment decision criteria. Mediterra has attended the Nov 2018 Tbilisi ESG Masterclass training provided by FMO and the Feb 2017 Belgrade ESG training proivded by IFC<br />
GLOBAL BEST PRACTICES<br />
Mediterra's partners have a mix of international and local private equity experience such as KKR, Lehman Brothers, Bedminster Capital Management, Is Private Equity<br />
OPERATIONS TEAM<br />
A dedicated operations team focusing on finance function and internal audit<br />
FOCUS ON BROADER TURKEY<br />
More than half of investments in Turkey have been in Anatolia
Mediterrania Capital Partners
Mediterrania Capital Partners is a dedicated private equity firm focusing North African and Sub-Saharan Africa growth investments in SMEs and mid cap companies. With offices in Abidjan, Algiers, Barcelona, Cairo, Casablanca and Valletta, Mediterrania Capital Partners takes a very intense hands-on and proactive approach to implementing its growth strategy, by leading the governance of the companies and driving the key internal value creation process.
Medivate Partners LLC
Founded in 2012, Medivate is one of the first private equity firms in Korea with the expertise in value investing cross-border life sciences industry. Medivate has been raised ~$80 million capital into 5 portfolio companies which include clinical stage biotech companies and contract development manufacturing organizations (CDMOs). Medivate’s management team has proven record in life sciences industry provides competitive advantage by leveraging strategic partnership with the portfolio companies, a key to the successful investment returns.
MedMen Capital
MedMen Enterprises is a leading cannabis company in the U.S. with assets and operations nationwide. MedMen owns and operates licensed cannabis facilities in cultivation, manufacturing and retail, and is the most recognized cannabis brand in the world today.
<br />
<br />
MedMen brings class leading operational expertise and unprecedented investment to the fast changing and fast-growing cannabis industry as it moves from its gray market legacy to a fully regulated, legitimate and commercially viable market.
MedScience Ventures
MedScience Ventures, LLC. (MSV) is a U.S., Europe, and Asia-based fund management company focused on emerging life science and medical technologies.
<br />
MSV seeks to partner with innovative, emerging companies to provide consulting services, obtain exclusive license rights in specific markets, and evaluate making equity investments.
Medu Capital
Established in 2003, Medu Capital is a professional investment management company with a focus on private equity. By providing long term capital and significant management skills, we partner with entrepreneurs to grow and develop privately owned businesses. Medu Capital is wholly owned by its management team.
Meeschaert Private Equity
Meeschaert Capital Partners is an independent investment company, born from the desire of the Meeschaert Group to expand its historical private management business with business leaders and their families, to support and support them in the development heritage and strategic of their companies.
Megalodon Capital Management
![Megalodon Capital Management]()
Megalodon is a financial consultancy firm. The firm is specialized in legal and fintech advisory<br />
focusing on digital securities. Megalodon founders have been part of the blockchain industry since 2011. With our combined network and knowledge in relation to blockchain (trading cryptocurrencies and assisting setting up blockchain businesses), we are able to provide our investors unprecedented access to the world of blockchain, whilst also operating within a regulated framework.
Meituan Dianping
Meituan was founded in March 2010 in Beijing as China's first groupbuy website. Today, Meituan is China's largest provider for local services with leading market position, tremendous annual turnover growth, and over 130 million annual active purchasers.
<br />
<br />
Meituan currently operates its businesses through three business units: Customers to Shop, Hotel Tourism, and Home Delivery Service, and a subsidiary Maoyan Movie.
